Quantum Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$526K Sell
2,092
-146
-7% -$31.4K 0.13% 100
2026
Q1
$487K Sell
2,238
-138
-6% -$30.6K 0.15% 94
2025
Q4
$543K Buy
2,376
+46
+2% +$10.5K 0.16% 92
2025
Q3
$539K Buy
2,330
+164
+8% +$33.4K 0.16% 96
2025
Q2
$402K Buy
2,166
+226
+12% +$42K 0.13% 112
2025
Q1
$406K Hold
1,940
0.15% 116
2024
Q4
$345K Sell
1,940
-41
-2% -$7.54K 0.11% 140
2024
Q3
$391K Hold
1,981
0.13% 133
2024
Q2
$340K Sell
1,981
-266
-12% -$44.1K 0.12% 140
2024
Q1
$409K Sell
2,247
-5
-0.2% -$862 0.15% 121
2023
Q4
$349K Sell
2,252
-300
-12% -$43.7K 0.15% 128
2023
Q3
$380K Sell
2,552
-261
-9% -$38.3K 0.18% 115
2023
Q2
$379K Sell
2,813
-250
-8% -$36.7K 0.18% 122
2023
Q1
$488K Sell
3,063
-1,500
-33% -$229K 0.26% 88
2022
Q4
$737K Sell
4,563
-200
-4% -$30.7K 0.47% 55
2022
Q3
$639K Sell
4,763
-650
-12% -$93.3K 0.4% 60
2022
Q2
$829K Sell
5,413
-5,315
-50% -$812K 0.49% 43
2022
Q1
$1.06M Sell
10,728
-500
-4% -$72.6K 0.46% 43
2021
Q4
$1.52M Buy
+11,228
New +$1.33M 0.58% 35

Other funds holding ABBV

Quantum Private Wealth's ABBV Position: Q2 2026 in Review

Quantum Private Wealth reduced its AbbVie (ABBV) stake by 6.5% in Q2 2026, selling an estimated $31.4K and leaving 2,092 shares worth $526K. The position accounts for 0.13% of the portfolio, ranked #100.

Quantum Private Wealth first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.52M in Q4 2021. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Quantum Private Wealth held 2,092 shares of AbbVie worth $526K as of Q2 2026.
  • Quantum Private Wealth sold 146 AbbVie shares in Q2 2026, an estimated $31.4K.
  • AbbVie made up 0.13% of Quantum Private Wealth's portfolio in Q2 2026, its #100 holding.
  • Quantum Private Wealth first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Quantum Private Wealth's AbbVie position peaked at $1.52M in Q4 2021.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Quantum Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.